Testing effectiveness (Phase 2)UnknownNCT05042128
What this trial is testing
The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Who this might be right for
Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Cancer
Australasian Gastro-Intestinal Trials Group 158